Health Care Declines as Abbott Labs, Elevance Slide on Earnings - Health Care Roundup

Dow Jones
2025/07/18

Health-care companies fell after a lackluster round of earnings.

Shares of medical-device maker Abbott Labs shares tumbled by more than 8% after it trimmed and narrowed its 2025 growth projections despite an increase in second-quarter sales.

Elevance shares slid after the health insurer slashed its projection for 2025 earnings, citing higher use of medical services by enrollees.

Bristol-Myers Squibb and Pfizer plan to sell the widely used blood thinner Eliquis directly to patients at a discounted cash price, a move that follows the Trump administration's pressure on the industry to cut drug prices.

 

Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

July 17, 2025 17:23 ET (21:23 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10